Continuous Glucose Monitoring for Type 2 Diabetes: How Does It Compare with Type 1 Diabetes?

Diabetes Technol Ther. 2022 Mar;24(3):153-156. doi: 10.1089/dia.2021.0374. Epub 2021 Oct 13.

Authors

Roy W Beck¹, Richard M Bergenstal²

Affiliations

¹ JAEB Center for Health Research, Tampa, Florida, USA.
² International Diabetes Center, HealthPartners Institute, Minneapolis, Minnesota, USA.

PMID: 34569811
DOI: 10.1089/dia.2021.0374

No abstract available

Publication types

Editorial

MeSH terms

Blood Glucose
Blood Glucose Self-Monitoring
Diabetes Mellitus, Type 1* / drug therapy
Diabetes Mellitus, Type 2* / drug therapy
Glycated Hemoglobin / analysis
Humans
Hypoglycemia*
Hypoglycemic Agents

Substances

Blood Glucose
Glycated Hemoglobin A
Hypoglycemic Agents